Biology
Develop GPCR-Based Drugs For The Treatment of Obesity and Type 2 Diabetes (T2D) by Exploring Metabolically Important Signaling Pathways in Immune Cells and Insulin-Sensitive Tissues (Liver, Pancreas, Skeletal Muscle, Adipose Tissue, and Brain)